Abstract
Background: The in vivo skin prick test (SPT) is widely considered less expensive than in vitro γ-immunoglobulin E (IgE) determination in the diagnosis of allergy. The aim of the present paper is to evaluate the relevance of component-resolved in vitro diagnosis in comparison to extract-based diagnosis and the relative global costs in relation to clinical outcomes.
Methods: For 50 individuals with suspected seasonal allergic rhinitis, we compared the costs of skin testing with those of specific IgE antibody measurement.
Results: The costs were higher for in vitro than in vivo testing. However, the clinical information obtained using recombinant reagents allowed correct identification of the sensitizing molecule.
Conclusions: Recombinant allergens for specific IgE in vitro measurement provide more reliable information for immunotherapy prescription. This should be translated into a significant reduction in the overall costs sustained by the healthcare system.
Clin Chem Lab Med 2007;45:391–5.
References
1. Dolen WK. It is not time to stop skin testing, but…J Allergy Clin Immunol2000;105:1074–6.10.1067/mai.2000.107151Search in Google Scholar
2. Plebani M. Clinical value and measurement of specific IgE [review]. Clin Biochem2003;36:453–69.10.1016/S0009-9120(03)00037-7Search in Google Scholar
3. Plebani M, Borghesan F, Faggian D. Clinical efficiency of in vitro and in vivo tests for allergic diseases. Ann Allergy Asthma Immunol1995;74:23–8.Search in Google Scholar
4. Ricci G, Capelli M, Miniero R, Menna G, Zannarini L, Dillon P, et al. A comparison of different allergometric tests, skin prick test, Pharmacia UniCAP and ADVIA Centaur, for diagnosis of allergic diseases in children. Allergy2003;58:38–45.10.1034/j.1398-9995.2003.23761.xSearch in Google Scholar
5. Prates S, Morais-Almeida M, Matos V, Loureiro V, Rosado-Pinto J. In vitro methods for specific IgE detection in cow's milk allergy. Allergol Immunopathol2006;34:27–31.10.1157/13084224Search in Google Scholar
6. Nolte H, DuBuske LM. Performance characteristics of a new automated enzyme immunoassay for the measurement of allergen-specific IgE. Summary of the probability outcomes comparing results of allergen skin testing to results obtained with the HYTEC system and CAP system. Ann Allergy Asthma Immunol1997;79:27–34.10.1016/S1081-1206(10)63080-3Search in Google Scholar
7. Hill DJ, Hosking CS, Reyes-Benito LV. Reducing the need for food allergen challenges in young children: a comparison of in vitro with in vivo tests. Clin Exp Allergy2001;31:1031–5.10.1046/j.1365-2222.2001.01113.xSearch in Google Scholar
8. Keskin O, Tuncer A, Adalioglu G, Sekerel BE, Sackesen C, Kalyci O. Evaluation of the utility of atopy patch testing, skin prick testing, and total and specific IgE assays in the diagnosis of cow's milk allergy. Ann Allergy Immunol2005;94:553–60.10.1016/S1081-1206(10)61133-7Search in Google Scholar
9. Valenta R, Lidholm J, Niederberger V, Hayek B, Kraft D, Gronlund H. The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy1999;29:896–904.10.1046/j.1365-2222.1999.00653.xSearch in Google Scholar PubMed
10. Mothes N, Valenta R, Spitzauer S. Rekombinante Allergene für die Diagnose der Typ I-Allergie. J Lab Med 2005;29:263–71; Mothes N, Valenta R, Spitzauer S. Allergy testing: the role of recombinant allergens. Clin Chem Lab Med2006;44:125–32.10.1515/JLM.2005.037Search in Google Scholar
11. Crameri R. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy. Immunol Allergy Clin North Am2006;26:179–89.10.1016/j.iac.2006.02.003Search in Google Scholar PubMed
12. Bousquet J, Lockey R, Malling HJ, Alvarez-Cuesta E, Canonica GW, Chapman MD, et al. Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American Academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol1998;81:401–5.10.1016/S1081-1206(10)63136-5Search in Google Scholar
13. Finegold I. What's in a name? Vaccine versus extracts. Ann Allergy Asthma Immunol1998;81:377.10.1016/S1081-1206(10)63133-XSearch in Google Scholar
14. Radauer C, Breiteneder H. Pollen allergens are restricted to few protein families and show distinct patterns of species distribution. J Allergy Clin Immunol2006;117:141–7.10.1016/j.jaci.2005.09.010Search in Google Scholar
15. Weber RW. Cross-reactivity of pollen allergens. Curr Allergy Asthma Rep2004;4:401–8.10.1007/s11882-004-0091-4Search in Google Scholar
16. Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W, et al. Long-term efficacy of grass-pollen immunotherapy. N Engl J Med1999;341:468–75.10.1056/NEJM199908123410702Search in Google Scholar
17. Eng PA, Reinhold M, Gnehm HP. Long-term efficacy of preseasonal grass pollen immunotherapy in children. Allergy2002;57:306–12.10.1034/j.1398-9995.2002.1o3264.xSearch in Google Scholar
18. Moller C, Dreborg S, Ferdousi HA, Halken S, Jacobsen L, Koivikko A, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT study). J Allergy Clin Immunol2002;109:251–6.10.1067/mai.2002.121317Search in Google Scholar
19. Valovirta E. Capacity of specific immunotherapy in prevention of allergic asthma in children: the preventive allergy treatment study (PAT). J Invest Allergol Clin Immunol1997;7:369.Search in Google Scholar
20. Società Italiana di Allergologia e Immunologia Clinica. Memorandum sulla diagnostica delle allergopatie. Giorn It Allergol Immunol Clin 1992;351:2–20.Search in Google Scholar
21. Williams PB, Dolen WK, Koepke JW, Selner JC. Comparison of skin testing and three in vitro assays for specific IgE in the clinical evaluation of immediate hyp-ersensitivity. Am Allergy1992;68:35–45.Search in Google Scholar
22. Lockey R, Lichtestein L, Bloch K, Kaliner M, Zweiman B, Rochelesky G. Position statement. The use of in vitro tests for IgE antibody in the specific diagnosis of the IgE-mediated disorders and in the formulation of allergen immunotherapy. J Allergy Clin Immunol1992;90:263–7.10.1016/0091-6749(92)90081-CSearch in Google Scholar
23. Pittner G, Vrtala S, Thomas WR, Weghofer M, Kundi M, Horak F, et al. Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens. Clin Exp Allergy2004;34:597–603.10.1111/j.1365-2222.2004.1930.xSearch in Google Scholar PubMed
24. Rossi RE, Monasterolo G. Evaluation of recombinant and native timothy pollen (rPhI p1,2,5,6,7,11,12 and nPhI p4)-specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients. Int Arch Allergy Immunol2004;135:44–53.10.1159/000080042Search in Google Scholar PubMed
25. Foetisch K, Westphal S, Lauer I, Retzek M, Altmann F, Kolarich D, et al. Biological activity of IgE specific for cross-reactive carbohydrate determinants. J Allergy Clin Immunol2003;111:889–96.10.1067/mai.2003.173Search in Google Scholar
26. Bousquet J, Becker WM, Hejjaoui A, Chanal I, Lebel B, Dhivert H, et al. Differences in clinical and immunologic reactivity of patients allergic to grass pollens and to multiple-pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with stand-ardized extracts. J Allergy Clin Immunol1991;88:43–53.10.1016/0091-6749(91)90299-4Search in Google Scholar
©2007 by Walter de Gruyter Berlin New York
